What We Do

A Feasibility Study of the...

This feasibility study will assess the effects of the Nativis Voyager therapy in patients with recurrent GBM who have either failed standard of care or...
VIEW

A Phase II Study of...

(Closed for new enrollments) The purpose of this research study is to find out whether adding an experimental vaccine called rindopepimut (also known as CDX-110)...
VIEW

A Phase II, Open-Label, Multi-Center...

This is a Phase II study to see if an investigational drug, ANG1005, can shrink tumor cells in breast cancer patients with recurrent brain metastases....
VIEW

A Phase III Clinical Trial...

The purpose of the study is to determine the safety and efficacy of an investigational therapy called DCVax®-L in patients with newly diagnosed GBM for...
VIEW

A Randomized, Double-Blind, Controlled Phase...

(Closed for new enrollments) This is a Phase II, multicenter study to determine the safety and efficacy of ICT-107 in treating a type of brain...
VIEW

ABT-414 alone or ABT-414 plus...

This study is to evaluate the efficacy and safety of ABT-414 alone or with temozolomide versus temozolomide or lomustine alone in participants with recurrent glioblastoma...
VIEW

An Expanded Access Protocol for...

The study is an open-label expanded access study for patients for whom vaccine was manufactured during the Northwest Biotherapeutics’ 020221 DCVax®-L for GBM screening process,...
VIEW

An International, Randomized, Double-Blind, Controlled...

(Closed for new enrollments) This 2-arm, randomized, Phase III study will investigate the efficacy and safety of the addition of rindopepimut (an experimental cancer vaccine...
VIEW

Hyperbaric Hyperoxygenation With Radiotherapy and...

Standard treatment for glioblastomas includes radiation and chemotherapy with a drug called temozolomide (Temodar); however, glioblastomas frequently develop resistance to standard treatment and recur or...
VIEW
1 2